Amazon, Facebook, and Google Join Forces to Aid Cancer Research

mobile handThree major companies; Amazon (NASDAQ:AMZN), Facebook (NASDAQ:FB), and Google (NASDAQ:GOOG) are contributing people and resources for an exciting new initiative to help cure cancer using a mobile app. Similar in concept to the web-based game Cell Slider, this new mobile app will “help cure cancer through gamification of cell analysis,” reports The Register.

The stock market is roaring back in 2013. Click here now to discover winning stocks!

Forty programmers, game specialists, and computer engineers are gathered at the East London Googleplex this weekend to work on this latest app that will allow users to contribute to the development of a cure for cancer. The mobile game app is tentatively title “GeneRun” and will allow users to aid cancer research by collectively analyzing some of the huge amount of gene data collected by cancer researchers in the UK.

Amazon has offered free cloud-hosting services as the game is developed. Facebook has contributed an engineering team for the weekend, while Google is hosting the GameJam event at its London Googleplex. The effort is also backed by the Citizen Science Alliance, a coalition of groups that promotes collective data-analysis to help solve large-data research problems.

Don’t Miss: How Big is Apple’s E-Book Economy?

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Premium Newsletters

Stock Investor Cheat Sheet

Stock Investor Cheat Sheet®

The ultimate Cheat Sheet for finding winning stock picks.
Learn More

Gold & Silver Newsletter

Gold & Silver

Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
Learn More

Commodities Premium Newsletter

Commodities Premium

There's always a bull market in some sector! Find the best opportunities in commodities.
Learn more

ETF Investing

ETF Investing

At last, a trading system that buys the right ETFs at the right time, time after time!
Learn more

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business